語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Cancer Biomarkers in Body Fluids = P...
~
SpringerLink (Online service)
Cancer Biomarkers in Body Fluids = Principles /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Cancer Biomarkers in Body Fluids/ by Gabriel D. Dakubo.
其他題名:
Principles /
作者:
Dakubo, Gabriel D.
面頁冊數:
XVI, 299 p. 46 illus., 44 illus. in color.online resource. :
Contained By:
Springer Nature eBook
標題:
Human genetics. -
電子資源:
https://doi.org/10.1007/978-3-319-01580-4
ISBN:
9783319015804
Cancer Biomarkers in Body Fluids = Principles /
Dakubo, Gabriel D.
Cancer Biomarkers in Body Fluids
Principles /[electronic resource] :by Gabriel D. Dakubo. - 1st ed. 2016. - XVI, 299 p. 46 illus., 44 illus. in color.online resource.
The molecular and genetic signatures of cancer are represented in the peripheral circulation and other body fluids, giving rise to the “liquid biopsy” concept. This new paradigm of molecular profiling of cancer cells offers several advantages over traditional tissue biopsy. It is convenient, noninvasive, conforms to current clinical practice, enables real time disease monitoring and the study of tumor evolution, can easily be sampled multiple times, and this sample is more representative of the heterogeneous cancer cells than biopsy sampling. Indeed, all aspects of cancer molecular genetic information, stemming from DNA (both nuclear and mitochondria), RNA (coding and noncoding), peptides and proteins, metabolites and lipids are present in body fluids as free, cell surface bound or enclosed in membrane vesicles, and are being harnessed for disease management. Additionally, circulating tumor, and tumor stem cells provide prognostic information, and also enable the study of the intricate molecular processes associated with metastasis and drug resistance. This treatise deals with the general principles of the molecular pathology of cancer, and its associated imprints in circulation. The transitional process from discovery, prototype development, translational research, to product development can be complex and costly. The critical path to biomarker development and qualification for successful use in drug development is detailed herein as well. This book is of interest to Cancer Researchers, Oncologists, Clinicians, Surgeons, Medical Students, Nurses, Diagnostic Laboratories, and Pharmaceutical Industries.
ISBN: 9783319015804
Standard No.: 10.1007/978-3-319-01580-4doiSubjects--Topical Terms:
596505
Human genetics.
LC Class. No.: RB155-155.8
Dewey Class. No.: 611.01816
Cancer Biomarkers in Body Fluids = Principles /
LDR
:03032nam a22004095i 4500
001
973543
003
DE-He213
005
20200706053341.0
007
cr nn 008mamaa
008
201211s2016 gw | s |||| 0|eng d
020
$a
9783319015804
$9
978-3-319-01580-4
024
7
$a
10.1007/978-3-319-01580-4
$2
doi
035
$a
978-3-319-01580-4
050
4
$a
RB155-155.8
050
4
$a
QH431
072
7
$a
MFN
$2
bicssc
072
7
$a
MED107000
$2
bisacsh
072
7
$a
MFN
$2
thema
082
0 4
$a
611.01816
$2
23
082
0 4
$a
599.935
$2
23
100
1
$a
Dakubo, Gabriel D.
$4
aut
$4
http://id.loc.gov/vocabulary/relators/aut
$3
1113276
245
1 0
$a
Cancer Biomarkers in Body Fluids
$h
[electronic resource] :
$b
Principles /
$c
by Gabriel D. Dakubo.
250
$a
1st ed. 2016.
264
1
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2016.
300
$a
XVI, 299 p. 46 illus., 44 illus. in color.
$b
online resource.
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
347
$a
text file
$b
PDF
$2
rda
520
$a
The molecular and genetic signatures of cancer are represented in the peripheral circulation and other body fluids, giving rise to the “liquid biopsy” concept. This new paradigm of molecular profiling of cancer cells offers several advantages over traditional tissue biopsy. It is convenient, noninvasive, conforms to current clinical practice, enables real time disease monitoring and the study of tumor evolution, can easily be sampled multiple times, and this sample is more representative of the heterogeneous cancer cells than biopsy sampling. Indeed, all aspects of cancer molecular genetic information, stemming from DNA (both nuclear and mitochondria), RNA (coding and noncoding), peptides and proteins, metabolites and lipids are present in body fluids as free, cell surface bound or enclosed in membrane vesicles, and are being harnessed for disease management. Additionally, circulating tumor, and tumor stem cells provide prognostic information, and also enable the study of the intricate molecular processes associated with metastasis and drug resistance. This treatise deals with the general principles of the molecular pathology of cancer, and its associated imprints in circulation. The transitional process from discovery, prototype development, translational research, to product development can be complex and costly. The critical path to biomarker development and qualification for successful use in drug development is detailed herein as well. This book is of interest to Cancer Researchers, Oncologists, Clinicians, Surgeons, Medical Students, Nurses, Diagnostic Laboratories, and Pharmaceutical Industries.
650
0
$a
Human genetics.
$3
596505
650
0
$a
Oncology .
$3
1253469
650
0
$a
Cancer research.
$3
1253664
650
1 4
$a
Human Genetics.
$3
593893
650
2 4
$a
Oncology.
$3
593951
650
2 4
$a
Cancer Research.
$3
668358
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer Nature eBook
776
0 8
$i
Printed edition:
$z
9783319015798
776
0 8
$i
Printed edition:
$z
9783319015811
776
0 8
$i
Printed edition:
$z
9783319791296
856
4 0
$u
https://doi.org/10.1007/978-3-319-01580-4
912
$a
ZDB-2-SBL
912
$a
ZDB-2-SXB
950
$a
Biomedical and Life Sciences (SpringerNature-11642)
950
$a
Biomedical and Life Sciences (R0) (SpringerNature-43708)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入